Search

Search Constraints

You searched for: Author/Creator Evrard, Jonathan

Search Results

1. Are the DOAC plasma level thresholds appropriate for clinical decision‐making? A reappraisal using thrombin generation testing. (10th October 2020)

2. Assessment of acquired activated protein C resistance with the FibWave and comparison with the ETP‐based APC resistance. (12th December 2020)

4. Comparison of analytical performances between clot waveform analysis and FibWave in edoxaban‐treated patients and healthy controls. Issue 7 (4th November 2022)

6. Development of new methodologies for the chromogenic estimation of betrixaban concentrations in plasma. (3rd January 2019)

7. Evaluation of a new thromboplastin reagent STA‐NeoPTimal on a STA R Max analyzer for the measurement of prothrombin time, international normalized ratio and extrinsic factor levels. (19th May 2020)

8. Optimal wavelength for the clot waveform analysis: Determination of the best resolution with minimal interference of the reagents. (7th February 2019)